Chlamydia trachomatis is the cause of trachoma, and following repeated infections the most damaging sequela is blindness. Over 15 serovariants of C. trachomatis have been described, and serovar-specific antigens are associated with protective immunity while broadly reacting antigens are associated with immunopathology. The major outer membrane protein (MOMP) of chlamydiae contains the serovar-specific antigen, however, this is an antigenically complex molecule that also contains subspecies- and species-specific antigens. Immunity to C. trachomatis eye infections is poorly understood, although animal models and human vaccine trials have demonstrated antibody mediated immune protection. The broad, long-term objectives of this proposal are 1) the evaluation of the human humoral response of trachoma tear samples to sequence-specific chlamydial epitopes and correlation of this data to clinical status, and 2) the development of a new amino acid sequence-defined immunoassay suitable for rapid seroepidemiological evaluations and assessments of immune status. These objectives will be of value for developing a basic understanding of immune mechanisms elicited during natural infection, and for developing and evaluating strategies for immune prophylactic intervention and for monitoring epidemiological intervention approaches.
The specific aims are: 1) Map the antigenic determinants for the 60K outer membrane protein using recombinant DNA expression in E. coli and peptide synthesis. Expression proteins and synthetic peptides will be identified and characterized using immune human and rabbit sera. 2) Evaluation of strain diversity for the MOMP gene of serovar-specific isolates obtained in trachoma endemic areas. This is accomplished using primer extension sequencing of mRNA isolated from infected tissue cultures. 3) Definition of the molecular basis of antigenic relatedness among serovariants. The DNA sequences of each of the 15 prototype serovars for the portion of the gene which encodes the serovar-specific epitope will determined and compared. Antisera will be obtained in rabbits immunized with synthetic peptides representing these epitopes, and the specificities of the antibody reactivities will define the molecular complexities of these relationships. 4) Develop an epidemiological immunoassay using serovar-specific DNA and amino acid sequence information to clone and express sequence-defined reagents for each of the 15 serovariants. These reagents will be constructed from synthetic oligonucleotides and expressed as fusion products of glutathione transferase. One-step affinity purification of these soluble fusion proteins will provide unlimited quantities of standardized material. 5) Determination of the human humoral response to antigenic domains and sequence-specific epitopes for the MOMP and 60K proteins. Tears obtained from trachoma studies will be evaluated for immunoglobulin classes and isotypes, and their quantity, avidity, and epitopic specificities will be evaluated.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY007757-01
Application #
3264813
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1988-08-01
Project End
1993-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Grimwood, J; Olinger, L; Stephens, R S (2001) Expression of Chlamydia pneumoniae polymorphic membrane protein family genes. Infect Immun 69:2383-9
Bain, D L; Lietman, T; Rasmussen, S et al. (2001) Chlamydial genovar distribution after community wide antibiotic treatment. J Infect Dis 184:1581-8
Stephens, R S; Koshiyama, K; Lewis, E et al. (2001) Heparin-binding outer membrane protein of chlamydiae. Mol Microbiol 40:691-9
Rasmussen-Lathrop, S J; Koshiyama, K; Phillips, N et al. (2000) Chlamydia-dependent biosynthesis of a heparan sulphate-like compound in eukaryotic cells. Cell Microbiol 2:137-44
Stephens, R S; Fawaz, F S; Kennedy, K A et al. (2000) Eukaryotic cell uptake of heparin-coated microspheres: a model of host cell invasion by Chlamydia trachomatis. Infect Immun 68:1080-5
Jones, H M; Kubo, A; Stephens, R S (2000) Design, expression and functional characterization of a synthetic gene encoding the Chlamydia trachomatis major outer membrane protein. Gene 258:173-81
Ellen, J M; Lammel, C J; Shafer, M A et al. (1999) Cervical secretory immunoglobulin A in adolescent girls. J Adolesc Health 25:150-4
Tomarev, S I; Tamm, E R; Chang, B (1998) Characterization of the mouse Myoc/Tigr gene. Biochem Biophys Res Commun 245:887-93
Tomarev, S I; Zinovieva, R D; Chang, B et al. (1998) Characterization of the mouse Prox1 gene. Biochem Biophys Res Commun 248:684-9
Chen, J C; Stephens, R S (1997) Chlamydia trachomatis glycosaminoglycan-dependent and independent attachment to eukaryotic cells. Microb Pathog 22:23-30

Showing the most recent 10 out of 31 publications